NIH-funded research R01 grant

Understanding blood clotting issues after COVID-19 infection and exploring new treatments

Official title: Molecular pathogenesis of COVID-19-associated coagulopathy and new therapeutic approaches

Funded at Scripps Research Institute, the · NIH-11004157 · Data updated 2026-11-12

This study is looking into how COVID-19 can cause blood clotting issues and problems with blood vessels, and it aims to find better treatments to help people who are dealing with these long-term effects.

More COVID-19 research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionScripps Research Institute, the
NIH-funded
Lab location1 site (La Jolla, United States)
Project startJanuary 1, 2024
Project endDecember 31, 2028
Funding year2025
Award (this year)$638,826
NIH project number5R01HL172048-02
Project IDNIH-11004157 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals who have experienced severe COVID-19 infections and are facing complications related to blood clotting.

Less likely to help

Patients who have not been infected with COVID-19 or those without any blood coagulation issues may not benefit from this research.

What this research studies

This research investigates the blood clotting problems that many patients experience after being infected with COVID-19. It focuses on understanding how the virus affects blood vessels and leads to conditions like blood clots and organ dysfunction. The researchers will explore various potential treatments to reduce these complications and improve patient outcomes. By studying the underlying mechanisms of these issues, the research aims to provide insights that could help manage and treat patients suffering from long-term effects of COVID-19.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that significantly reduce blood clotting complications in COVID-19 patients.

How similar studies have gone: Other research has shown promising results in understanding blood clotting issues related to COVID-19, indicating that this area of study is both relevant and necessary.

Where this research is happening

  • Scripps Research Institute, the
    La Jolla, United States
    Active

Researchers

  • Principal investigator: Aiolfi, Roberto — Scripps Research Institute, the
  • Study coordinator: Aiolfi, Roberto

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.